A key aspect behind why MDMA is demonstrating effectiveness for the management and treatment of PTSD in a clinical setting, is its apparent ability to assist patients to be more expressive during a controlled psychotherapy session. MDMA appears to reduce anxiety associated with recalling traumatic experiences allowing for increased insight and memory. Negative memories are perceived as less negative allowing for the therapist and the patient to engage in productive therapeutic sessions without the patient becoming hyper-aroused due to stress.
Last month the Association of State and Provincial Psychology Boards (ASPPB) quietly posted a message that the new Part 2 of the national licensing exam will officially launch on January 1, 2020. ASPPB officials first announced the new test, the EPPP-2, in 2017 as optional for its member jurisdictions. Then as resistance mounted, ASPPB’s Board of Directors decided that they would combine parts and make the entire exam mandatory, this coupled with a 100% fee increase.
Telehealth and telepsychology offer increased access to therapy for individuals with physical, medical and/or mobility disabilities. Benefits include more flexible scheduling, access to therapy in native languages (e.g., American sign language) and other advantages. Types of services and answers to frequently asked questions are listed below for both consumers and practitioners who are considering telehealth or telepsychology.
Loneliness has been described as a common source of discomfort based on a subjective discrepancy between the actual and desired social situation. For some people this feeling may become a sustained state that is associated with a wide range of psychiatric and psychosocial problems. While there are few existing treatment protocols, interventions based on cognitive behavior therapy (CBT) have shown positive effects.